Chemed Earnings Watch: Can They Deliver? | Business and Finance News

Chemed’s Q2 earnings drop Tuesday, with market expecting a strong 7.5% revenue jump—up from last year’s 3.8%—after they surprised with a solid Q1 performance. Analysts are bullish, and with peers like Tenet and UnitedHealth also beating targets, Chemed’s 11.1% stock surge this month hints at momentum. Can they deliver again and keep investors excited? Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/430796edd255dc65